| 2025-10-08 | +59.6% | news | Stock Titan | 40‑Hz 15mA DIFS improves cognition: Nexalin's Gen‑2 SYNC shows fMRI connectivity gains in mild AD - Stock Titan |
| 2025-10-08 | +59.6% | news | StocksToTrade | Is Nexalin’s Stock Set to Skyrocket? - StocksToTrade |
| 2025-10-08 | +59.6% | news | StocksToTrade | Nexalin Technology Inc. (NXL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade |
| 2025-10-08 | +59.6% | news | Investing.com South Africa | Nexalin stock soars after Alzheimer’s treatment shows cognitive benefits By Investing.com - Investing.com South Africa |
| 2024-06-18 | +45.7% | legal | SEC EDGAR | NXL 8-K: 8.01 and (SEC Filing) |
| 2024-06-28 | -43.7% | news | Seeking Alpha | Nexalin Technology stock slides on pricing stock offering to raise $5.2 million |
| 2024-06-28 | -43.7% | legal | SEC EDGAR | NXL 8-K: 1.01, 8.01 (SEC Filing) |
| 2024-04-16 | -32.6% | news | Seeking Alpha | Nexalin Technology files to offer common stock worth $5.65M |
| 2025-05-05 | -28.2% | news | Seeking Alpha | Nexalin Technology slides after pricing $5M stock offering |
| 2025-05-05 | -28.2% | legal | SEC EDGAR | NXL 8-K: 1.01 and (SEC Filing) |
| 2022-09-18 | -25.7% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Nexalin Technology, Inc. (NXL) - Zacks Investment Research |
| 2022-09-18 | -25.7% | news | Zacks Investment Research | Should I buy Nexalin Technology, Inc. (NXL) - Zacks Investment Research |
| 2025-07-21 | +16.3% | legal | SEC EDGAR | NXL 8-K: 5.02 and (SEC Filing) |
| 2026-04-14 | +16.1% | news | GlobeNewswire | Join Nexalin’s Exclusive Live Investor Webinar and Q&A Session on April 21 |
| 2026-04-14 | +16.1% | executive | Stock Titan | Nexalin CEO to outline mental health device strategy April 21 - Stock Titan |
| 2024-07-03 | -15.6% | legal | SEC EDGAR | NXL 8-K: 1.01, 8.01 (SEC Filing) |
| 2026-04-09 | +14.3% | news | GlobeNewswire | Nexalin Announces Peer-Reviewed Study Showing the Company’s DIFS™ Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents |
| 2026-04-09 | +14.3% | news | Stock Titan | Nexalin teen pilot finds noninvasive brain stimulation cut self-harm - Stock Titan |
| 2022-09-20 | -14.3% | legal | SEC EDGAR | NXL 8-K: 1.01, 8.01 (SEC Filing) |
| 2026-02-23 | +13.6% | news | Stock Titan | Congress boosts brain stimulation research for veterans, with Nexalin involved - Stock Titan |
| 2026-04-10 | +12.5% | news | Cổng thông tin điện tử Tỉnh Sơn La | Are investors bearish on Nexalin Technology (NXL) Stock | Price at $0.39, Up 1.32% - Trending Momentum Stocks - Cổng thông tin điện tử Tỉnh Sơn La |
| 2024-11-10 | -12.2% | news | Yahoo Finance | Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Invest In Growth? - Yahoo Finance |
| 2024-04-26 | +10.6% | legal | SEC EDGAR | NXL 8-K: 8.01 and (SEC Filing) |
| 2026-04-16 | -10.5% | news | Simply Wall St. | ASX Stocks That May Be Trading Below Their Estimated Value |
| 2026-02-05 | -10.0% | expansion | Investing.com | Nexalin Technology stock rises after launching AI-powered virtual clinic - Investing.com |
| 2026-02-05 | -10.0% | news | Stock Titan | Home-based brain therapy: Nexalin, UCSD roll out AI virtual clinic - Stock Titan |
| 2026-04-23 | -9.7% | earnings | Cổng thông tin điện tử tỉnh Tây Ninh | NXL (Nexalin Technology Inc.) reports narrow Q4 2025 EPS miss, shares rise 18 percent on positive investor sentiment. - Binary Event - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2022-09-22 | -9.6% | earnings | MarketBeat | Nexalin Technology (NXL) Stock Price, News & Analysis $NXL - MarketBeat |
| 2022-09-22 | -9.6% | earnings | MarketBeat | Nexalin Technology (NXL) Earnings Date and Reports 2026 $NXL - MarketBeat |
| 2025-10-10 | -9.5% | news | Yahoo Finance | Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Deliver On Growth Plans? - Yahoo Finance |
| 2025-09-22 | +9.2% | legal | SEC EDGAR | NXL 8-K: 8.01 and (SEC Filing) |
| 2024-11-01 | +8.6% | legal | SEC EDGAR | NXL 8-K: 8.01 and (SEC Filing) |
| 2025-12-20 | -8.1% | news | Trefis | Nexalin Technology Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis |
| 2024-05-17 | -7.8% | news | StockInvest.us | Historical NXL stock prices (quote) - Nexalin Technology, Inc. - StockInvest.us |
| 2026-04-15 | +7.1% | legal | GlobeNewswire | Nexalin Advances FDA Alzheimer’s Strategy Following Landmark Leadership Meetings in the U.S. and China |
| 2026-04-15 | +7.1% | legal | Stock Titan | After FDA and China meetings, Nexalin reshapes Alzheimer’s study - Stock Titan |
| 2026-04-15 | +7.1% | news | Cổng thông tin điện tử tỉnh Tây Ninh | What to Know About Nexalin Technology (NXL) Stock Today (Institutional Demand) 2026-04-15 - Target Price - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2024-04-11 | -7.0% | legal | SEC EDGAR | NXL 8-K: 8.01 and (SEC Filing) |
| 2023-09-28 | -6.5% | legal | SEC EDGAR | NXL 8-K: 5.02 (SEC Filing) |
| 2024-05-19 | -6.2% | earnings | MarketBeat | Nexalin Technology (NXL) Stock Forecast and Price Target 2026 $NXL - MarketBeat |
| 2024-03-14 | +5.9% | news | Seeking Alpha | Nexalin Technology commences sales of gen-2 neurostimulation device in Oman |
| 2025-05-06 | -5.6% | legal | SEC EDGAR | NXL 8-K: 1.01, 8.01 (SEC Filing) |
| 2022-09-30 | -5.4% | news | ChartMill | NXL Stock Price, Quote & Chart | NEXALIN TECHNOLOGY INC (NASDAQ:NXL) - ChartMill |
| 2026-01-23 | -5.1% | news | Seeking Alpha | Nexalin Technology receives Nasdaq bid price deficiency notice |
| 2026-01-23 | -5.1% | legal | SEC EDGAR | NXL 8-K: 3.01, 8.01 (SEC Filing) |
| 2026-01-23 | -5.1% | news | Stock Titan | Nexalin has 180 days to lift Nasdaq share price back to $1 - Stock Titan |
| 2026-04-20 | -5.0% | news | ACCESS Newswire | RedChip's Biotech Investor Conference Replays Now Available |
| 2026-04-20 | -5.0% | news | Cổng thông tin điện tử Tỉnh Sơn La | Nexalin Technology (NXL) Stock: Why Growth Investors Chase It (-2.65%) 2026-04-20 - Hedge Fund Inspired Picks - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-04-20 | -5.0% | news | UBND thành phố Hải Phòng | Nexalin Technology (NXL) Stock: Why Growth Investors Chase It (-2.65%) 2026-04-20 - High Volume Stocks - UBND thành phố Hải Phòng |
| 2024-07-16 | -4.8% | legal | SEC EDGAR | NXL 8-K: 8.01 (SEC Filing) |
| 2025-05-27 | -4.7% | news | Intellectia AI | NXL Forecast — Price Prediction for 2026. Should I Buy NXL? - Intellectia AI |
| 2023-04-06 | +4.5% | news | CoinCodex | Nexalin Technology, Inc. (NXL) Stock Forecast & Price Prediction 2026–2030 - CoinCodex |
| 2025-02-06 | +4.5% | legal | SEC EDGAR | NXL 8-K: 8.01 and (SEC Filing) |
| 2024-07-30 | -4.5% | legal | SEC EDGAR | NXL 8-K: 5.02 (SEC Filing) |
| 2026-04-06 | +4.0% | news | Cổng thông tin điện tử tỉnh Lào Cai | Is Nexalin Technology (NXL) Stock Good for Beginners | Price at $0.36, Up 2.33% - Crowd Consensus Signals - Cổng thông tin điện tử tỉnh Lào Cai |
| 2024-01-11 | +4.0% | news | Stock Titan | Nexalin Technology Unveils Next-Generation HALO™ Clarity - Stock Titan |
| 2024-09-19 | +3.6% | legal | SEC EDGAR | NXL 8-K: 5.02 and (SEC Filing) |
| 2025-06-09 | -3.4% | legal | SEC EDGAR | NXL 8-K: 8.01 and (SEC Filing) |
| 2025-10-15 | +3.3% | legal | SEC EDGAR | NXL 8-K: 1.01 and (SEC Filing) |
| 2025-10-15 | +3.3% | news | Investing.com | Nexalin Technology expands at-the-market offering to $10 million - Investing.com |
| 2025-04-21 | +2.9% | news | Stock Titan | Medicare May Cover AI Mental Health Devices as Nexalin Backs New Bill | NXL Stock News - Stock Titan |
| 2026-03-29 | -2.7% | news | Simply Wall St. | Three High Growth Tech Stocks in Australia |
| 2025-04-23 | +2.6% | news | Seeking Alpha | Nexalin Technology files $50M common stock offering |
| 2025-08-04 | +2.1% | legal | SEC EDGAR | NXL 8-K: 5.02 and (SEC Filing) |
| 2026-04-03 | +1.8% | news | Xã Thanh Hà | NXL Stock Analysis: Nexalin Technology Inc. sits at $0.35 with mild 0.73% daily dip - Xã Thanh Hà |
| 2026-04-22 | -1.8% | earnings | GlobeNewswire | Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment |
| 2026-04-22 | -1.8% | legal | SEC EDGAR | NXL 8-K: 1.01, 7.01 (SEC Filing) |
| 2026-04-22 | -1.8% | legal | Stock Titan | Nexalin lines up 160-patient insomnia study to support FDA filing - Stock Titan |
| 2026-04-22 | -1.8% | earnings | Xã Thanh Hà | NXL Nexalin Technology Q4 2025 earnings narrowly miss consensus estimates, shares tick higher as investors overlook minor shortfall. - Stock Analysis Community - Xã Thanh Hà |
| 2026-04-22 | -1.8% | news | Stock Titan | Nexalin (NXL) funds 160-patient pivotal HALO Clarity insomnia trial - Stock Titan |
| 2025-04-24 | +1.7% | news | Stock Titan | NXL Stock Price, News & Analysis - Stock Titan |
| 2025-05-28 | -1.5% | news | Stock Titan | Revolutionary Mental Health Tech: Nexalin Unveils Game-Changing Treatment in $537B Market Webinar - Stock Titan |
| 2026-02-24 | +1.3% | earnings | GlobeNewswire | Nexalin Announces Pivotal HALO™ Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market |
| 2026-02-24 | +1.3% | news | Stock Titan | Drug-free insomnia device trial targets 30 million adults - Stock Titan |
| 2023-06-02 | -1.3% | legal | SEC EDGAR | NXL 8-K: 1.01 and (SEC Filing) |
| 2023-06-01 | +1.1% | news | Seeking Alpha | Nexalin Technology, Wider Come Limited formalize JV pact |
| 2026-04-02 | +0.8% | news | ACCESS Newswire | RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference |
| 2024-04-25 | +0.8% | news | Seeking Alpha | Nexalin Technology regains compliance with Nasdaq continued listing requirements |
| 2026-04-17 | -0.8% | news | Simply Wall St. | April 2026 Global's Top Undervalued Small Caps With Insider Action |
| 2026-04-21 | +0.5% | analyst | ChartMill | NXL Forecast, Price Target & Analyst Ratings | NEXALIN TECHNOLOGY INC (NASDAQ:NXL) - ChartMill |
| 2025-08-01 | -0.5% | executive | Seeking Alpha | Nexalin Technology appoints Justin Fleet as CFO |
| 2025-08-01 | -0.5% | executive | Seeking Alpha | Nexalin Technology appoints Justin Van Fleet as CFO |
| 2025-04-02 | -0.4% | expansion | Stock Titan | Revolutionary Brain Treatment: Nexalin Launches PTSD Trial at UCSD with AI-Powered Home Therapy - Stock Titan |
| 2024-01-04 | +0.2% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2026-04-08 | +0.1% | legal | Stock Titan | NXL SEC Filings - Nexalin Tech 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2025-12-05 | -0.1% | legal | SEC EDGAR | NXL 8-K: 8.01 and (SEC Filing) |
| 2026-04-26 | — | news | Quantisnow | Nexalin Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Quantisnow |
| 2022-09-16 | — | news | Seeking Alpha | Neurostimulation device maker Nexalin stock drops 51% after $10M IPO (update) |
| 2022-09-16 | — | news | Seeking Alpha | Medical devices firm Nexalin prices ~$9.6M IPO |
| 2022-09-16 | — | legal | SEC EDGAR | NXL 8-K: 1.01, 8.01 (SEC Filing) |
| 2022-09-16 | — | news | TradingView | NXL Stock Price and Chart — NASDAQ:NXL - TradingView |